Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0367604 USE OF EGG YOLK OIL AND THE BENZOPYRENE-ELIMINATED EGG YOLK OIL IN THE TREATMENT OF ALLERGIC RHINITIS
The application of egg yolk oil, as well as benzopyrene-eliminated egg yolk oil, is prepared for medicaments for the treatment of allergic rhinitis. By topical...
2016/0367603 Methods for Modulating Skin Inflammation
The invention is directed to novel methods for modulating inflammatory and/or immune responses. Such methods utilize compositions comprising extraembryonic...
2016/0367602 Methods for treating hidradenitis suppurativa
The invention is directed to methods for treating Hidradenitis Suppurativa. Specifically, the invention is directed to treating and reducing inflammation...
2016/0367601 PREPARATION METHOD FOR THERAPEUTIC AGENT OF BEAD-TYPE CHONDROCYTE
The present invention relates to a preparation method for a therapeutic agent of a bead-type chondrocyte and, more specifically, to: a preparation method for a...
2016/0367600 Administration of Intact Mammalian Cells to the Brain by the Intranasal Route
The present invention provides an intranasal method for delivery of intact mammalian cells to the brain for treatment of neurological deficits. This approach...
2016/0367599 USE OF PLATELET RICH PLASMA COMPOSITION IN THE TREATMENT OF CARDIAC CONDUCTION ABNORMALITIES
Methods and kits for treating a cardiac arrhythmia using a platelet rich plasma (PRP) composition are provided. Any type of arrhythmia may be treated using the...
2016/0367598 MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the...
2016/0367597 DIALYSIS PRECURSOR COMPOSITION
A dialysis acid precursor assembly including a dialysis acid precursor composition of dry components including anhydrous glucose, a dry acid, a magnesium...
2016/0367596 TOPICAL AND ORAL FORMULATIONS COMPRISING TAURINE AND MAGNESIUM FOR THE PREVENTION AND TREATMENT OF ACNE
Topical and oral compositions for treating and/or preventing acne are disclosed. The compositions include effective amounts of taurine and magnesium, wherein...
2016/0367595 PRODUCTION OF WATER-SOLUBLE HYDROLYZED CLINOPTILOLITE FRAGMENTS AND NUTRACEUTICAL PRODUCTS BASED ON...
Methods are provided to make clinoptilolite into a water-soluble hydrolyzed form suitable for various administration routes, including oral administration....
2016/0367594 SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS
Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining...
2016/0367593 LIQUID CHALCOGENIDE COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME
The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of...
2016/0367592 SODIUM NITRITE-CONTAINING PHARMACEUTICAL COMPOSITIONS
Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the...
2016/0367591 SULFATED POLYGULONIC ACID POLYSACCHARIDE OR PHARMACEUTICAL SALT THEREOF, PREPARATION METHOD THEREFOR AND USE...
A polygulonic acid sulfate or pharmaceutically acceptable salt thereof, preparation method therefor and use thereof in the preparation of tumor growth and/or...
2016/0367590 PHOSPHOLIPID COMPOSITIONS AND USE THEREOF TO ENHANCE SPERMATOZOA MOTILITY AND VIABILITY
Sperm mobility and impregnation of an oocyte is enhanced by placing sperm in an aqueous solution of phospholipids prior to in vitro fertilization or artificial...
2016/0367589 MODULATION OF THE PHYSICAL INTERACTION BETWEEN PLATELETS AND THE CELL SURFACE EFFECTING CELL PROLIFERATION
The growth and/or proliferation of mammalian cells are modulated by modulating the physical interaction between platelets (thrombocytes) and the surface of the...
2016/0367588 TALEN-BASED GENE CORRECTION
The invention is directed to transcription activator-like effector nuclease (TALEN)-mediated DNA editing of disease-causing mutations in the context of the...
2016/0367587 Systemic In Vivo Delivery of Oligonucleotides
This invention provides a method for the systemic in vivo delivery of oligonucleotides. The invention utilizes the presence of one or plurality of HES linked...
2016/0367586 COMBINATION, KIT AND METHOD OF REDUCING INTRAOCULAR PRESSURE
The present invention is directed to a combination or a kit comprising a prostaglandin analog and an adenosine receptor A.sub.1 agonist and to a method of...
2016/0367585 NOVEL AMINOGLYCOSIDE ANTIBIOTICS, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL USE THEREOF
The present invention relates to novel aminoglycoside antibiotics, a process for producing the same, and pharmaceutical use thereof. More specifically, the...
2016/0367584 PROTECTIVE AGENT FOR KERATOCONJUNCTIVA OR SUPPRESSIVE AGENT FOR KERATOCONJUNCTIVAL DISORDER
An object of the present invention is to provide a protective agent for the keratoconjunctiva or a suppressive agent for a keratoconjunctival disorder having...
2016/0367583 COMPOSITIONS AND METHODS FOR BOROCARBOHYDRATE COMPLEXES
Borocarbohydrate complex containing compositions are presented that have an improved di-complex to boric acid ratio. In some embodiments, compositions are...
2016/0367582 THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN...
The presently disclosed subject matter provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP)...
2016/0367581 THERAPY REGIMEN AND METHODS TO SENSITIZE CANCER CELLS TREATED WITH EPIGENETIC THERAPY TO PARP INHIBITORS IN...
The presently disclosed subject matter provides methods to treat cancer cells using low doses of DNA demethylating agents and poly ADP ribose polymerase (PARP)...
2016/0367580 IMPROVED EXTENDED-ACTION TILMICOSIN AND USE THEREOF IN TREATMENT OF BOVINE RESPIRATORY DISEASE COMPLEX (BRD)...
The invention relates to an improved long-acting or extended-release tilmicosin formulation comprising: tilmicosin phosphate in a concentration between 35 and...
2016/0367579 PREBIOTIC FORMULATIONS AND METHODS OF USE
The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal...
2016/0367578 METHODS AND COMPOSITIONS FOR ERADICATING LEUKEMIC CELLS
The disclosure relates to compositions, methods, and kits comprising glycyrrhetinic acid derivatives for selectively eradicating leukemic cells in a population...
2016/0367577 Synthetic composition for treating metabolic disorders
The invention relates to a method for stabilising or reducing insulin resistance in patients having an obesity-related, metabolic disorder, the method...
2016/0367576 ANTIMICROBIAL FORMULATIONS
A pharmaceutical formulation is disclosed which includes an acrylic acid polymer and boric acid at a pH of less then about 5.0 and more than about 2.0
2016/0367575 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, salts and hydrates of the prodrugs, compositions comprising...
2016/0367574 Dialysis Solution, Use Of A Dialysis Solution And Chemical Compound
The present invention relates to a dialysis solution having at least one osmotic agent, wherein the osmotic agent is starch propylphosphonate.
2016/0367573 DIALYSIS SOLUTIONS COMPRISING ORGANIC ESTERS OF PHOSPHORIC ACID
This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an...
2016/0367572 METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
The invention generally relates to methods for identifying and using anticancer therapeutic agents and, more particularly, to methods for identifying and using...
2016/0367571 USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANAEMIA
The present invention discloses the use of paricalcitol, a synthetic Vitamin D analogue, in the treatment of inflammatory anaemia, preferably in combination...
2016/0367570 TOPICAL COMPOSITIONS AND METHODS FOR TREATING PSORIASIS
Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
2016/0367569 HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods of...
2016/0367568 Method of Testing for Endometriosis and Treatment Therefor
The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for...
2016/0367567 ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
The invention provides an orodispersible solid pharmaceutical dosage unit having a weight between 30 and 1,000 mg, said dosage unit comprising: 0.1-25 wt. % of...
2016/0367566 PHARMACEUTICAL COMPOSITIONS FOR ANESTHESIOLOGICAL APPLICATIONS
Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a .beta.-blocker and...
2016/0367565 DEVICES AND METHODS OF TREATING METHAMPHETAMINE ADDICTION AND MEDICAL AND BEHAVIORAL CONSEQUENCES OF...
A method of treating a condition of in a human patient comprising pharmacologically activating a translocator protein of 18 kDa (TSPO), wherein the condition...
2016/0367564 Pharmaceutical Compound
Provided is a tryptophan-2,3-dioxygenase (TDO) and/or indoleamine-2,3-dioxygenase (IDO) inhibitor compound for use in medicine, which compound comprises the...
2016/0367563 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, COMPOSITIONS, AND THEIR USE
In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): (I) and include...
2016/0367562 USE OF DIHYDROIMIDAZOLONES FOR THE TREATMENT OF DOGS
The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one]...
2016/0367561 COMPOSITIONS AND METHODS FOR SENSITIZING A NEOPLASTIC CELL TO RADIATION
The invention provides for the use of radiation sensitizing agents in combination with radiation for the treatment of neoplasia, methods for the identification...
2016/0367560 Methods for Treating Parkinson's Disease
The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second...
2016/0367559 Time Released Caffeine
A pill that increases the availability of caffeine in the bloodstream of a user by delaying release of the drug from the stomach for the treatment of...
2016/0367558 METHODS AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS
The present invention is directed to a novel methods and compositions for the therapeutic intervention in hyperphenylalaninemia. More specifically, the...
2016/0367557 HETEROCYCLIC PYRIMIDINE CARBONIC ACID DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT, AMELIORATION OR PREVENTION...
The present invention relates to a compound having the general formula (C), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph,...
2016/0367556 Therapeutic Agent for Ocular Disease or Prophylactic Agent for Ocular Disease
Because 3-[(3S, 4R)-3-Methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan- -1-yl]-3-oxopropanenitrile suppresses an increase of the retinal...
2016/0367555 Use of a Receptor-Type Kinase Modulator for Treating Polycystic Kidney Disease
The invention comprises a method of treating polycystic kidney disease (PKD) in a mammal, such as a human or feline (e.g., Persian cat), comprising...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.